This value is approximately $1.5$ times $\pi$ ($1.5 \times 3.14159 \approx 4.71$). Indeed, mathematically: $$ \frac{156}{33} = \frac{52}{11} = 4 + \frac{8}{11} $$ $$ \pi \approx 3.14159 $$
The recurrence of "156 (33%)" across disparate fields—oncology, endocrinology, and pediatrics—suggests it is a common subset size in clinical trials aimed at achieving statistical power. While the number 156 itself is the raw count, the 33% proportion often marks a "significant minority" within a study, representing a group that either lacks access to care, receives a specific treatment, or experiences a particular complication. Key Study Summary Table Context of 156/33 Key Finding 52/156 (33%) informed 156/33
The GCD is $3$.
Dividing both the numerator and the denominator by $3$: $$ \frac{156}{33} = \frac{156 \div 3}{33 \div 3} = \frac{52}{11} $$ This value is approximately $1
High frequency of MMR involvement in "wrong dose" safety incidents. Key Study Summary Table Context of 156/33 Key